Outcome Of Bench Trial Disputed By Patent Owners In Federal Circuit Appeal

(August 31, 2017, 2:01 PM EDT) -- WASHINGTON, D.C. — A Delaware federal judge’s ruling, following a bench trial, that four patents covering thrice-weekly injections of 40 mg glatiramer acetate (GA) are invalid was erroneous, the makers of...
To view the full article, register now.